SAB BIOTHERAPEUTICS, INC. Shares Issued, Price Per Share
SAB BIOTHERAPEUTICS, INC. (SABS) had Shares Issued, Price Per Share of $0.01 per share as of 2020-11-20, per its 10-K filed 2021-04-02.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:SharesIssuedPricePerShare · last filed 2021-04-02
- 2020-11-20: Shares Issued, Price Per Share $0.01.
| Period end | Shares Issued, Price Per Share |
|---|---|
| 2020-11-20 | $0.01 10-K · filed 2021-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |